Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Supplementary software
-
Reference no. UVA-S-F-0792
Published by: Darden Business Publishing
Published in: 1988
Format: .xls
Data source: Field research
Topics: Finance

Abstract

This software is to accompany the case. This negotiation case is meant to be used in conjunction with 'Eli Lilly and Company'; half the class works from one case and half from the other. Lilly is considering acquiring Hybritech, but the genetic-engineering company's future cash flows are difficult to predict and value. Both companies want to effect the merger, but the cases, which provide essentially the same information in all other respects, provide widely divergent projected cash flows.

About

Abstract

This software is to accompany the case. This negotiation case is meant to be used in conjunction with 'Eli Lilly and Company'; half the class works from one case and half from the other. Lilly is considering acquiring Hybritech, but the genetic-engineering company's future cash flows are difficult to predict and value. Both companies want to effect the merger, but the cases, which provide essentially the same information in all other respects, provide widely divergent projected cash flows.

Settings


Related